261 related articles for article (PubMed ID: 26538004)
1. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
[No Abstract] [Full Text] [Related]
2. VII. Management of nodular lymphocyte-predominant Hodgkin lymphoma.
Eichenauer DA; Engert A
Hematol Oncol; 2013 Jun; 31 Suppl 1():47-50. PubMed ID: 23775649
[No Abstract] [Full Text] [Related]
3. Nodular lymphocyte predominant Hodgkin lymphoma with non-invasive or early invasive growth pattern suggests an early step of the disease with a highly favorable outcome.
Carbone A; Spina M; Gloghini A; Ponzoni M; Doglioni C; Tirelli U
Am J Hematol; 2013 Feb; 88(2):161-2. PubMed ID: 23349009
[No Abstract] [Full Text] [Related]
4. [IF-RT alone remains gold standard for stage IA nodular lymphocyte-predominant Hodgkin lymphoma].
Pilz K; Jentsch C; Krause M
Strahlenther Onkol; 2016 Jun; 192(6):428-30. PubMed ID: 27194138
[No Abstract] [Full Text] [Related]
5. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin Lymphoma: Diagnosis and Treatment.
Ansell SM
Mayo Clin Proc; 2015 Nov; 90(11):1574-83. PubMed ID: 26541251
[TBL] [Abstract][Full Text] [Related]
7. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
8. [Guideline for childhood Hodgkin's lymphoma].
;
Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):586-9. PubMed ID: 25224235
[No Abstract] [Full Text] [Related]
9. Nodular lymphocyte predominant hodgkin lymphoma: biology, diagnosis and treatment.
Goel A; Fan W; Patel AA; Devabhaktuni M; Grossbard ML
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):261-70. PubMed ID: 24650975
[TBL] [Abstract][Full Text] [Related]
10. Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents--a comprehensive review of biology, clinical course and treatment options.
Shankar A; Daw S
Br J Haematol; 2012 Nov; 159(3):288-98. PubMed ID: 22994199
[TBL] [Abstract][Full Text] [Related]
11. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
Rueda Domínguez A; Alfaro Lizaso J; de la Cruz Merino L; Gumá I Padró J; Quero Blanco C; Gómez Codina J; Llanos Muñoz M; Martinez Banaclocha N; Rodriguez Abreu D; Provencio Pulla M
Clin Transl Oncol; 2015 Dec; 17(12):1005-13. PubMed ID: 26497354
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategies for pediatric nodular lymphocyte predominant Hodgkin's lymphoma.
Vassilakopoulos TP; Angelopoulou MK; Pangalis GA
Leuk Lymphoma; 2006 Aug; 47(8):1450-1. PubMed ID: 16966251
[No Abstract] [Full Text] [Related]
13. [Malignant lymphoma in pediatrics].
Ise T
Rinsho Hoshasen; 1985 Oct; 30(11):1415-25. PubMed ID: 3910879
[No Abstract] [Full Text] [Related]
14. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).
Lo AC; Major A; Super L; Appel B; Shankar A; Constine LS; Marks LJ; Kelly KM; Metzger ML; Buhtoiarov IN; Mauz-Körholz C; Costa ARS; Binkley MS; Flerlage J
Leuk Lymphoma; 2022 Aug; 63(8):1997-2000. PubMed ID: 35357263
[No Abstract] [Full Text] [Related]
15. Lymphocyte-predominant Hodgkin disease: a comprehensive overview.
Bose S; Ganesan C; Pant M; Lai C; Tabbara IA
Am J Clin Oncol; 2013 Feb; 36(1):91-6. PubMed ID: 21358294
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of 2 patients treated with
Golstein SC; Muylle K; Vercruyssen M; Spilleboudt C; de Wind A; Bron D
Eur J Haematol; 2018 Sep; 101(3):415-417. PubMed ID: 29719928
[TBL] [Abstract][Full Text] [Related]
17. Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups.
Shankar AG; Roques G; Kirkwood AA; Lambilliotte A; Freund K; Leblanc T; Hayward J; Abbou S; Ramsay AD; Schmitt C; Gorde-Grosjean S; Pacquement H; Haouy S; Boudjemaa S; Aladjidi N; Hall GW; Landman-Parker J
Br J Haematol; 2017 Apr; 177(1):106-115. PubMed ID: 28220934
[TBL] [Abstract][Full Text] [Related]
18. Treatment of nodular lymphocyte-predominant Hodgkin lymphoma-"do no harm".
Bartlett NL
Clin Adv Hematol Oncol; 2013 Jun; 11(6):385-7. PubMed ID: 24472810
[No Abstract] [Full Text] [Related]
19. Paediatric lymphocyte-predominant Hodgkin's lymphoma.
Burki TK
Lancet Oncol; 2016 Jul; 17(7):e272. PubMed ID: 27237611
[No Abstract] [Full Text] [Related]
20. Metachronous and clonally related classic Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma.
Ding Y; Campbell A; Zhang X; Fu K; Yuan J
Pathology; 2021 Feb; 53(2):285-288. PubMed ID: 32951907
[No Abstract] [Full Text] [Related]
[Next] [New Search]
